• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国慢性荨麻疹的患病率估计:一项性别和年龄调整的人群分析。

Prevalence estimates for chronic urticaria in the United States: A sex- and age-adjusted population analysis.

机构信息

Department of Dermatology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, New Hyde Park, New York.

Department of Dermatology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, New Hyde Park, New York.

出版信息

J Am Acad Dermatol. 2019 Jul;81(1):152-156. doi: 10.1016/j.jaad.2019.02.064. Epub 2019 Mar 11.

DOI:10.1016/j.jaad.2019.02.064
PMID:30872154
Abstract

BACKGROUND

Disease burden in chronic urticaria (CU) is poorly understood.

OBJECTIVE

To estimate standardized overall and sex-, age-, and race-specific prevalence estimates for CU among adults in the United States.

METHODS

A cross-sectional analysis with electronic health records data for a demographically heterogeneous population-based sample of >55 million patients across all 4 census regions.

RESULTS

The overall CU prevalence was 0.23%, or 230 CU cases/100,000 adults. The adjusted prevalence in women was 310 (95% confidence interval [CI] 307-312) cases/100,000 adults, more than twice that of men (146 [95% CI 143-148] cases/100,000 adults, P < .001). CU prevalence was highest among patients aged 40-49 years (256 [95% CI 252-261] cases/100,000 adults) and 50-59 years (246 [95% CI 242-251] cases/100,000 adults) compared with all other age groups (P < .0001). Adjusted prevalences for black (292 [95% CI 285-298] cases/100,000 adults) and other (331 [95% CI 323-338] cases/100,000 adults) patients were higher than that for white patients (262 [95% CI 260-264] cases/100,000 adults; P < .001).

LIMITATIONS

Use of administrative data has the potential to underestimate burden.

CONCLUSION

There are >500,000 people estimated to have CU in the United States, most of whom are women or adults ≥40 years of age.

摘要

背景

慢性荨麻疹(CU)的疾病负担了解甚少。

目的

估计美国成年人 CU 的标准化总体患病率以及性别、年龄和种族特异性患病率。

方法

使用电子健康记录数据对来自四个普查区域的超过 5500 万患者进行基于人群的异质人群进行横断面分析。

结果

CU 的总体患病率为 0.23%,即每 10 万名成年人中有 230 例 CU 病例。女性调整后的患病率为 310(95%置信区间[CI]307-312)例/10 万成年人,是男性的两倍多(146 [95%CI 143-148] 例/10 万成年人,P <.001)。CU 患病率在 40-49 岁(256 [95%CI 252-261] 例/10 万成年人)和 50-59 岁(246 [95%CI 242-251] 例/10 万成年人)的患者中最高,与所有其他年龄组相比(P <.0001)。与白人患者(262 [95%CI 260-264] 例/10 万成年人;P <.001)相比,黑人(292 [95%CI 285-298] 例/10 万成年人)和其他种族(331 [95%CI 323-338] 例/10 万成年人)患者的调整后患病率更高。

局限性

使用行政数据可能会低估负担。

结论

美国估计有超过 50 万人患有 CU,其中大多数为女性或≥40 岁的成年人。

相似文献

1
Prevalence estimates for chronic urticaria in the United States: A sex- and age-adjusted population analysis.美国慢性荨麻疹的患病率估计:一项性别和年龄调整的人群分析。
J Am Acad Dermatol. 2019 Jul;81(1):152-156. doi: 10.1016/j.jaad.2019.02.064. Epub 2019 Mar 11.
2
Epidemiology of urticaria in Spain.西班牙荨麻疹的流行病学
J Investig Allergol Clin Immunol. 2004;14(3):214-20.
3
Prevalence estimates for pyoderma gangrenosum in the United States: An age- and sex-adjusted population analysis.美国坏疽性脓皮病的流行率估计:年龄和性别调整后的人群分析。
J Am Acad Dermatol. 2020 Aug;83(2):425-429. doi: 10.1016/j.jaad.2019.08.001. Epub 2019 Aug 7.
4
Prevalence estimates for pemphigoid in the United States: A sex-adjusted and age-adjusted population analysis.美国天疱疮的流行率估计:一项经过性别调整和年龄调整的人口分析。
J Am Acad Dermatol. 2019 Mar;80(3):655-659. doi: 10.1016/j.jaad.2018.08.030. Epub 2018 Aug 28.
5
Hyperlipidemia Is Associated with Chronic Urticaria: A Population-Based Study.高脂血症与慢性荨麻疹相关:一项基于人群的研究。
PLoS One. 2016 Mar 10;11(3):e0150304. doi: 10.1371/journal.pone.0150304. eCollection 2016.
6
Characterization of chronic urticaria and associated conditions in a large population of adolescents.青少年人群中慢性荨麻疹及相关疾病的特征。
J Am Acad Dermatol. 2019 Jul;81(1):129-135. doi: 10.1016/j.jaad.2019.02.034. Epub 2019 Feb 21.
7
Epidemiology and comorbidities of patients with chronic urticaria in Korea: A nationwide population-based study.韩国慢性荨麻疹患者的流行病学和合并症:一项全国基于人群的研究。
J Dermatol. 2018 Jan;45(1):10-16. doi: 10.1111/1346-8138.14075. Epub 2017 Oct 6.
8
Psoriasis prevalence among adults in the United States.美国成年人银屑病患病率。
J Am Acad Dermatol. 2014 Mar;70(3):512-6. doi: 10.1016/j.jaad.2013.11.013. Epub 2014 Jan 2.
9
Physical urticaria: Review on classification, triggers and management with special focus on prevalence including a meta-analysis.物理性荨麻疹:分类、诱发因素及管理综述,特别关注患病率,包括一项荟萃分析。
Postgrad Med. 2015 Aug;127(6):565-70. doi: 10.1080/00325481.2015.1045817. Epub 2015 May 10.
10
Clinical features of elderly chronic urticaria.老年慢性荨麻疹的临床特征
Korean J Intern Med. 2014 Nov;29(6):800-6. doi: 10.3904/kjim.2014.29.6.800. Epub 2014 Oct 31.

引用本文的文献

1
Effect of Dietary Intervention in Paediatric Patients with Chronic Spontaneous Urticaria: Open Labelled Randomised Controlled Trial.饮食干预对儿童慢性自发性荨麻疹患者的影响:开放标签随机对照试验。
Maedica (Bucur). 2025 Jun;20(2):275-282. doi: 10.26574/maedica.2025.20.2.275.
2
Prevalence and Association of Autoimmune Comorbidities Among Adults with Vitiligo: A Systematic Literature Review and Meta-analysis of USA-Based Studies.白癜风成年患者自身免疫性合并症的患病率及相关性:基于美国研究的系统文献综述和荟萃分析
Dermatol Ther (Heidelb). 2025 Aug 19. doi: 10.1007/s13555-025-01506-y.
3
Factors Influencing Relapse After Omalizumab in Chronic Urticaria. Does the Method of Discontinuation Influence Relapse?
影响慢性荨麻疹患者接受奥马珠单抗治疗后复发的因素。停药方法是否会影响复发?
Dermatol Pract Concept. 2025 Jul 31;15(3):5196. doi: 10.5826/dpc.1503a5196.
4
Clinical profile, prevalence, and burden of chronic spontaneous urticaria in the United States.美国慢性自发性荨麻疹的临床特征、患病率及负担
World Allergy Organ J. 2025 Jul 18;18(8):101081. doi: 10.1016/j.waojou.2025.101081. eCollection 2025 Aug.
5
Biological and target synthetic treatments for chronic spontaneous urticaria: A systematic review and network meta-analysis.慢性自发性荨麻疹的生物治疗和靶向合成治疗:一项系统评价和网状Meta分析
Clin Transl Allergy. 2025 May;15(5):e70052. doi: 10.1002/clt2.70052.
6
Incidence and Prevalence of Chronic Spontaneous Urticaria Among Adult and Pediatric Populations in the United States.美国成人和儿童人群中慢性自发性荨麻疹的发病率和患病率
Adv Ther. 2025 Jun;42(6):2808-2820. doi: 10.1007/s12325-025-03172-0. Epub 2025 Apr 16.
7
Is there a difference between women and men in chronic spontaneous urticaria? A systematic review on gender and sex differences in CSU patients.慢性自发性荨麻疹在女性和男性之间存在差异吗?关于慢性自发性荨麻疹患者性别差异的系统评价。
World Allergy Organ J. 2024 Oct 12;17(11):100974. doi: 10.1016/j.waojou.2024.100974. eCollection 2024 Nov.
8
Evaluation of Bilastine's Efficacy and Safety in Treating Chronic Idiopathic Urticaria in Iraqi Patients.比拉斯汀治疗伊拉克慢性特发性荨麻疹患者的疗效和安全性评估。
Med J Islam Repub Iran. 2024 Oct 21;38:121. doi: 10.47176/mjiri.38.121. eCollection 2024.
9
Relationship between cigarette smoking and chronic spontaneous urticaria. Is there a difference in neutrophil-lymphocyte ratio?吸烟与慢性自发性荨麻疹之间的关系。中性粒细胞与淋巴细胞比值是否存在差异?
Postepy Dermatol Alergol. 2024 Dec;41(6):617-621. doi: 10.5114/ada.2024.143640. Epub 2024 Sep 30.
10
Sexual Dysfunction in Chronic Urticaria: A Systematic Review.慢性荨麻疹中的性功能障碍:一项系统评价。
Dermatol Ther (Heidelb). 2025 Jan;15(1):31-44. doi: 10.1007/s13555-024-01319-5. Epub 2024 Dec 11.